Loading...
iRhythm Technologies, Inc.
IRTC•NASDAQ
Healthcare
Medical - Devices
$134.18
$1.89(1.43%)
iRhythm Technologies, Inc. (IRTC) Financial Performance & Income Statement Overview
Review iRhythm Technologies, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
20.13%
↑ 20.13%
Operating Income Growth
7.71%
↑ 7.71%
Net Income Growth
8.20%
↑ 8.20%
Operating Cash Flow Growth
106.77%
↑ 106.77%
Operating Margin
-17.77%
↓ 17.77%
Gross Margin
69.39%
↑ 69.39%
Net Profit Margin
-15.89%
↓ 15.89%
ROE
-112.84%
↓ 112.84%
ROIC
-13.49%
↓ 13.49%
iRhythm Technologies, Inc. (IRTC) Income Statement & Financial Overview
Review iRhythm Technologies, Inc.'s (IRTC) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $164.32M | $147.54M | $148.05M | $131.93M |
| Cost of Revenue | $49.26M | $46.06M | $44.58M | $44.41M |
| Gross Profit | $115.07M | $101.48M | $103.47M | $87.52M |
| Gross Profit Ratio | $0.70 | $0.69 | $0.70 | $0.66 |
| R&D Expenses | $19.38M | $15.69M | $19.69M | $16.99M |
| SG&A Expenses | $99.77M | $103.38M | $106.76M | $108.66M |
| Operating Expenses | $119.15M | $119.07M | $126.45M | $125.65M |
| Total Costs & Expenses | $168.11M | $165.13M | $171.03M | $170.07M |
| Interest Income | $5.74M | $6.46M | $6.38M | $2.95M |
| Interest Expense | $3.32M | $3.33M | $3.31M | $2.86M |
| Depreciation & Amortization | $6.60M | $6.40M | $6.40M | $6.38M |
| EBITDA | $8.74M | -$36.27M | -$10.20M | -$36.40M |
| EBITDA Ratio | $0.05 | -$0.25 | -$0.07 | -$0.28 |
| Operating Income | -$4.08M | -$50.30M | -$22.98M | -$38.14M |
| Operating Income Ratio | -$0.02 | -$0.34 | -$0.16 | -$0.29 |
| Other Income/Expenses (Net) | $2.90M | $4.31M | $3.07M | -$7.50M |
| Income Before Tax | -$1.18M | -$45.99M | -$19.91M | -$45.63M |
| Income Before Tax Ratio | -$0.007 | -$0.31 | -$0.13 | -$0.35 |
| Income Tax Expense | $151000.00 | $188000.00 | $194000.00 | $32000.00 |
| Net Income | -$1.33M | -$46.18M | -$20.11M | -$45.67M |
| Net Income Ratio | -$0.008 | -$0.31 | -$0.14 | -$0.35 |
| EPS | -$0.04 | -$1.48 | -$0.65 | -$1.47 |
| Diluted EPS | -$0.04 | -$1.48 | -$0.65 | -$1.47 |
| Weighted Avg Shares Outstanding | $31.34M | $31.26M | $31.14M | $31.03M |
| Weighted Avg Shares Outstanding (Diluted) | $31.34M | $31.26M | $31.14M | $31.03M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan